Related Experiment Video
Updated: Jan 3, 2026
08:08
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
16.9K
Proteomic research in sarcomas - current status and future opportunities
Jessica Burns1, Christopher P Wilding1, Robin L Jones2
1Division of Molecular Pathology, The Institute of Cancer Research, London, SW3 6JB, UK.
Seminars in Cancer Biology
|November 14, 2019
Summary
Proteomics research is advancing the understanding of rare mesenchymal cancers called sarcomas. Integrating proteomics into sarcoma studies can improve diagnosis, prognosis, and treatment for these complex diseases.
Area of Science:
- Oncology
- Proteomics
- Genomics
Background:
- Sarcomas are rare mesenchymal cancers with over 70 subtypes.
- Limited molecular understanding hinders progress in sarcoma prognosis and therapeutics.
- Proteomics offers a promising avenue for advancing sarcoma research.
Purpose of the Study:
- To review proteomic strategies applied to sarcoma research.
- To evaluate key proteomic studies across various rare sarcoma subtypes.
- To illustrate the potential of proteomics in advancing sarcoma understanding and clinical application.
Main Methods:
- Review of existing proteomic studies in sarcoma research.
- Evaluation of proteomic data for specific rare and ultra-rare sarcoma subtypes.
- Discussion of integration strategies for proteomics with other molecular data and clinical trials.
Main Results:
- Proteomic research has focused on histological subtype characterization.
- Identification of potential diagnostic, predictive, and prognostic biomarkers is ongoing.
- No proteomic findings have been translated into clinical practice yet.
Conclusions:
- Routine implementation of proteomics can enhance biological understanding of sarcomas.
- Integrating proteomics with other molecular data is crucial.
- Incorporating proteomics into clinical trials may accelerate progress in sarcoma care.
Related Concept Videos
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:33Proteomics
9.2K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
9.2K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K